The BRCC3 regulated by Cdk5 promotes the activation of neuronal NLRP3 inflammasome in Parkinson’s disease models
Authors:
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 522 (3) , 647-654
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangxi Province
- National Natural Science Foundation of China
This publication has 42 references indexed in Scilit:
- Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the InflammasomeJournal of Biological Chemistry, 2013
- Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome ActivationJournal of Biological Chemistry, 2012
- Loss of BRCC3 Deubiquitinating Enzyme Leads to Abnormal Angiogenesis and Is Associated with Syndromic MoyamoyaThe American Journal of Human Genetics, 2011
- Differential Regulation of JAMM Domain Deubiquitinating Enzyme Activity within the RAP80 ComplexJournal of Biological Chemistry, 2010
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic interventionNeurobiology of Disease, 2010
- Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 ExpressionThe Journal of Immunology, 2009
- The NALP3 inflammasome is involved in the innate immune response to amyloid-βNature Immunology, 2008
- Endocytosis: the DUB versionTrends in Cell Biology, 2006
- Ubiquitin signalling in the NF-κB pathwayNature Cell Biology, 2005
- Cell Cycle–Regulated Modification of the Ribosome by a Variant Multiubiquitin ChainCell, 2000